SEMA3C and astrocytoma (excluding glioblastoma): Analysis of human brain tumor samples revealed that Sema3C protein levels are markedly increased in glioblastoma (grade IV) compared to grade I–III astrocytomas, and this increase in Sema3C expression was associated with shorter survival time [51].